SCHEMBL12947964

SCHEMBL12947964

COc1cc(F)c2nc(C)c3c(C)nc(CI)n3c2c1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 20/20 0.58
PDE10A Q9Y233 20/20 0.58
PDE11A Q9HCR9 4/20 0.46
PDE5A O76074 3/20 0.46
PDE4A P27815 2/20 0.46
PDE6D O43924 1/20 0.42
PDE6A P16499 1/20 0.42
PDE6G P18545 1/20 0.42
PDE6B P35913 1/20 0.42
PDE6C P51160 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
PDE3B Q13370 1/20 0.42
PDE6H Q13956 1/20 0.42
PDE3A Q14432 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12947966 0.87 PDE10A (0.57) PDE2APDE10APDE11APDE5APDE4A
SCHEMBL12948061 0.81 PDE10A (0.60) PDE2APDE10APDE11APDE5APDE4A
SCHEMBL970411 0.80 PDE10A (0.61) PDE2APDE10APDE11APDE5APDE4A
SCHEMBL970666 0.74 PDE10A (0.55) PDE2APDE10APDE11APDE5APDE4A
SCHEMBL969322 0.74 PDE10A (0.77) PDE2APDE10APDE11APDE5APDE4A
SCHEMBL969450 0.73 PDE10A (1.00) PDE2APDE10APDE11APDE5APDE4A
SCHEMBL972085 0.73 PDE10A (1.00) PDE2APDE10APDE11APDE5APDE4A
SCHEMBL969397 0.73 PDE2A (0.76) PDE2APDE10APDE11APDE5APDE4A
SCHEMBL970617 0.72 PDE10A (0.74) PDE2APDE10APDE11APDE5APDE4A
SCHEMBL970252 0.72 PDE10A (1.00) PDE2APDE10APDE11APDE5APDE6D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875618-B2 8-chloro-3,4-dimethyl-1-(2- methylphenyl)imidazo[1,5- a]quinoxaline; inhibitors of phosphodiesterase 10; for treatment of central nervous system disorders (cognitive deficits, social phobia, reduced vigilance, obesity and psychosis) WYETH (US) 2011-01-25 US disclosed